Meta‐analysis of the cumulative risk of endometrial malignancy and systematic review of endometrial surveillance in extended tamoxifen therapy. BJS 2018; 105: 1098-1106.
Authors: C. A. Fleming, H. M. Heneghan, D. O'Brien, D. P. McCartan, E. W. McDermott, R. S. Prichard et al.
Notes: Counselling of patients important
Breast‐conserving surgery followed by whole‐breast irradiation offers survival benefits over mastectomy without irradiation. BJS 2018; 105: 1607-1614.
Authors: J. de Boniface, J. Frisell, L. Bergkvist, Y. Andersson
Notes: Radiotherapy to lower axilla key?
Is axillary ultrasound imaging necessary for all patients with breast cancer?. BJS 2018; 105: 930-932.
Authors: M. Ahmed, M. Douek
Meta‐analysis of the oncological safety of autologous fat transfer after breast cancer. BJS 2018; 105: 1082-1097.
Authors: T. K. Krastev, S. J. Schop, J. Hommes, A. A. Piatkowski, E. M. Heuts, R. R. W. J. van der Hulst et al.
Notes: Lipofilling ok
Omission of surgery in older women with early breast cancer has an adverse impact on breast cancer‐specific survival. BJS 2018; 105: 1454-1463.
Authors: S. E. Ward, P. D. Richards, J. L. Morgan, G. R. Holmes, J. W. Broggio, K. Collins et al.
Notes: Surgery should be first choice
Risk of recurrence and death in patients with breast cancer after delayed deep inferior epigastric perforator flap reconstruction. BJS 2018; 105: 1435-1445.
Authors: H. Adam, A. C. Docherty Skogh, Å. Edsander Nord, I. Schultz, J. Gahm, P. Hall et al.
Notes: Deep inferior epigastric perforator is safe
Predictors of complications after direct‐to‐implant breast reconstruction with an acellular dermal matrix from a multicentre randomized clinical trial. BJS 2018; 105: 1305-1312.
Authors: V. L. Negenborn, R. E. G. Dikmans, M. B. Bouman, H. A. H. Winters, J. W. R. Twisk, P. Q. Ruhé et al.
Notes: Not good for the large breast
Population‐based study of the sensitivity of axillary ultrasound imaging in the preoperative staging of node‐positive invasive lobular carcinoma of the breast. BJS 2018; 105: 987-995.
Authors: E. Morrow, A. Lannigan, J. Doughty, J. Litherland, J. Mansell, S. Stallard et al.
Notes: Less sensitive in lobular carcinoma
Routine histopathological examination after female‐to‐male gender‐confirming mastectomy. BJS 2018; 105: 885-892.
Authors: S. M. J. Van Renterghem, J. Van Dorpe, S. J. Monstrey, J. Defreyne, K. E. Y. Claes, M. Praet et al.
Notes: The case for
Meta‐analysis of neoadjuvant therapy and its impact in facilitating breast conservation in operable breast cancer. BJS 2018; 105: 469-481.
Authors: A. Karakatsanis, M. K. Tasoulis, F. Wärnberg, G. Nilsson, F. MacNeill
Notes: Still unnecessary mastectomies
Baseline factors predicting a response to neoadjuvant chemotherapy with implications for non‐surgical management of triple‐negative breast cancer. BJS 2018; 105: 535-543.
Authors: R. F. D. van la Parra, A. B. Tadros, C. M. Checka, G. M. Rauch, A. Lucci, B. D. Smith et al.
Notes: Ductal carcinoma in situ and microcalcification important
Authors: Z. E. Winters, J. R. Benson
Impact of specialist management on survival from radiation‐associated angiosarcoma of the breast. BJS 2018; 105: 401-409.
Authors: L. Feinberg, A. Srinivasan, J. K. Singh, M. Parry, J. Stevenson, L. Jeys et al.
Notes: Improves outcomes
Minimizing inequality in access to precision medicine in breast cancer by real‐time population‐based molecular analysis in the SCAN‐B initiative. BJS 2018; 105: e158-e168.
Authors: L. Rydén, N. Loman, C. Larsson, C. Hegardt, J. Vallon‐Christersson, M. Malmberg et al.
Notes: Promising Swedish initiative
Authors: M. A. Stammes, S. L. Bugby, T. Porta, K. Pierzchalski, T. Devling, C. Otto et al.
Notes: Visible results
Authors: P. McAnena, A. Lowery, M. J. Kerin
Notes: Promising technology
MiR‐128 regulation of glucose metabolism and cell proliferation in triple‐negative breast cancer. BJS 2018; 105: 75-85.
Authors: M. Xiao, C. Lou, H. Xiao, Y. Yang, X. Cai, C. Li et al.
Notes: New molecular target?
International validation of the European Organisation for Research and Treatment of Cancer QLQ‐BRECON23 quality‐of‐life questionnaire for women undergoing breast reconstruction. BJS 2018; 105: 209-222.
Authors: Z. E. Winters, M. Afzal, C. Rutherford, B. Holzner, G. Rumpold, R. A. da Costa Vieira et al.
Notes: Useful tool